Literature DB >> 1594189

Bilateral retinoblastoma. Correlations between age at diagnosis and time course for new intraocular tumors.

D H Abramson1, D S Greenfield, R M Ellsworth.   

Abstract

A retrospective analysis of 355 eyes from 325 patients with bilateral retinoblastoma followed for at least five years was analyzed for the development of new ocular tumors. Eighty-eight eyes (24.8%) developed new tumors with more than 95% of these seen in patients diagnosed before the age of two years. Excluding one patient, no new tumors were seen in patients who were initially diagnosed after 33 months of age. The relative risk for developing new tumors was greater (45.1%) for patients diagnosed within the first six months of life than for patients diagnosed after the age of six months (14.2%). The highest percentage of patients (58%) to develop new tumors were those diagnosed before the age of three months. In patients initially treated before two years of age, new tumors were noted to develop up to 4.5 years later, whereas among eyes diagnosed after the age of two years, 100% of all new tumors were seen before 1.5 years of follow-up. Regardless of the age at diagnosis, however, the upper age limit for new tumor development ranged from 4.0-6.25 years, with a mean of 5.1 years. All new tumors were managed with either photocoagulation/cryotherapy or plaques.

Entities:  

Mesh:

Year:  1992        PMID: 1594189     DOI: 10.3109/13816819209070046

Source DB:  PubMed          Journal:  Ophthalmic Paediatr Genet        ISSN: 0167-6784


  6 in total

1.  Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?

Authors:  D S Gombos; P A Cauchi; J L Hungerford; P Addison; P G Coen; J E Kingston
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

Review 2.  A Review of Recurrent Retinoblastoma: Children's Hospital Los Angeles Classification and Treatment Guidelines.

Authors:  Jesse L Berry; Kaitlin Kogachi; A Linn Murphree; Rima Jubran; Jonathan W Kim
Journal:  Int Ophthalmol Clin       Date:  2019

3.  Epidemiological trends in 1452 cases of retinoblastoma from the Surveillance, Epidemiology, and End Results (SEER) registry.

Authors:  Michael T Andreoli; Felix Y Chau; Michael J Shapiro; Yannek I Leiderman
Journal:  Can J Ophthalmol       Date:  2017-07-22       Impact factor: 1.882

Review 4.  Current management strategies for intraocular retinoblastoma.

Authors:  Jonathan W Kim; David H Abramson; Ira J Dunkel
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Unilateral retinoblastoma: new intraocular tumours after treatment.

Authors:  D H Abramson; L S Gamell; R M Ellsworth; E F Kruger; C A Servodidio; L Turner; D Sussman
Journal:  Br J Ophthalmol       Date:  1994-09       Impact factor: 4.638

6.  Classification of Vitreous Seeds in Retinoblastoma: Correlations with Patient, Tumor, and Treatment Characteristics.

Authors:  Jasmine H Francis; Brian P Marr; David H Abramson
Journal:  Ophthalmology       Date:  2016-03-27       Impact factor: 12.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.